reported that hnRNP-U is highly expressed in bladder cancer, and inhibited hnRNP-U may improve chemotherapy sensitivity by enhancing cisplatin-induced apoptosis of bladder cancer cells (52). This evidence concerns the gene HNRNPU and urinary bladder carcinoma.